Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients in Latin America
The incidence of acute kidney injury (AKI) in hospitalized patients with COVID-19 is broad and ranges from 0.5 to 29% according to early reports from China and Italy [1, 2]. A recent multicenter retrospective cohort in New York showed a higher incidence (37%) and mortality (35%). AKI was primaril...
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
Kidney Blood Press Res
2020
|
| Materias: | |
| Acceso en línea: | http://eprints.uanl.mx/25048/1/37.pdf |
| _version_ | 1824420071235125248 |
|---|---|
| author | Claure Del Granado, Rolando Casas Aparicio, Gustavo Rosa Diez, Guillermo Rizo Topete, Lilia María Ponce, Daniela |
| author_facet | Claure Del Granado, Rolando Casas Aparicio, Gustavo Rosa Diez, Guillermo Rizo Topete, Lilia María Ponce, Daniela |
| author_sort | Claure Del Granado, Rolando |
| collection | Repositorio Institucional |
| description | The incidence of acute kidney injury (AKI) in hospitalized patients with COVID-19 is
broad and ranges from 0.5 to 29% according to early reports from China and Italy [1, 2]. A
recent multicenter retrospective cohort in New York showed a higher incidence (37%) and
mortality (35%). AKI was primarily seen in COVID-19 patients with respiratory failure; 89.7%
of patients who were on mechanical ventilation developed AKI as compared to just 21.7% of
non-ventilated patients. Furthermore, 96.8% of patients who required renal replacement
therapy (RRT) were on ventilators [3]. From these first reports, AKI emerges at the same time
as the acute respiratory distress syndrome, and the development of AKI is usually found in
patients who progress to phase 3 of the extra-pulmonary systemic hyper-inflammation
syndrome [4]. Hirsch et al. [3] reported that up to 37.3% of AKI cases occurred within the first
24 h of hospital admission, and AKI frequently coincides with the development of the hyperinflammation
phase |
| format | Article |
| id | eprints-25048 |
| institution | UANL |
| language | English |
| publishDate | 2020 |
| publisher | Kidney Blood Press Res |
| record_format | eprints |
| spelling | eprints-250482023-05-18T19:01:07Z http://eprints.uanl.mx/25048/ Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients in Latin America Claure Del Granado, Rolando Casas Aparicio, Gustavo Rosa Diez, Guillermo Rizo Topete, Lilia María Ponce, Daniela R Medicina en General The incidence of acute kidney injury (AKI) in hospitalized patients with COVID-19 is broad and ranges from 0.5 to 29% according to early reports from China and Italy [1, 2]. A recent multicenter retrospective cohort in New York showed a higher incidence (37%) and mortality (35%). AKI was primarily seen in COVID-19 patients with respiratory failure; 89.7% of patients who were on mechanical ventilation developed AKI as compared to just 21.7% of non-ventilated patients. Furthermore, 96.8% of patients who required renal replacement therapy (RRT) were on ventilators [3]. From these first reports, AKI emerges at the same time as the acute respiratory distress syndrome, and the development of AKI is usually found in patients who progress to phase 3 of the extra-pulmonary systemic hyper-inflammation syndrome [4]. Hirsch et al. [3] reported that up to 37.3% of AKI cases occurred within the first 24 h of hospital admission, and AKI frequently coincides with the development of the hyperinflammation phase Kidney Blood Press Res 2020-10 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/25048/1/37.pdf http://eprints.uanl.mx/25048/1.haspreviewThumbnailVersion/37.pdf Claure Del Granado, Rolando y Casas Aparicio, Gustavo y Rosa Diez, Guillermo y Rizo Topete, Lilia María y Ponce, Daniela (2020) Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients in Latin America. Published by S. Karger AG, Basel, 1 (1). pp. 775-783. ISSN 2020;45:775–783 https://www.karger.com/our-contents |
| spellingShingle | R Medicina en General Claure Del Granado, Rolando Casas Aparicio, Gustavo Rosa Diez, Guillermo Rizo Topete, Lilia María Ponce, Daniela Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients in Latin America |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | Renal Replacement Therapy for Acute
Kidney Injury in COVID-19 Patients in
Latin America |
| title_full | Renal Replacement Therapy for Acute
Kidney Injury in COVID-19 Patients in
Latin America |
| title_fullStr | Renal Replacement Therapy for Acute
Kidney Injury in COVID-19 Patients in
Latin America |
| title_full_unstemmed | Renal Replacement Therapy for Acute
Kidney Injury in COVID-19 Patients in
Latin America |
| title_short | Renal Replacement Therapy for Acute
Kidney Injury in COVID-19 Patients in
Latin America |
| title_sort | renal replacement therapy for acute kidney injury in covid 19 patients in latin america |
| topic | R Medicina en General |
| url | http://eprints.uanl.mx/25048/1/37.pdf |
| work_keys_str_mv | AT clauredelgranadorolando renalreplacementtherapyforacutekidneyinjuryincovid19patientsinlatinamerica AT casasapariciogustavo renalreplacementtherapyforacutekidneyinjuryincovid19patientsinlatinamerica AT rosadiezguillermo renalreplacementtherapyforacutekidneyinjuryincovid19patientsinlatinamerica AT rizotopeteliliamaria renalreplacementtherapyforacutekidneyinjuryincovid19patientsinlatinamerica AT poncedaniela renalreplacementtherapyforacutekidneyinjuryincovid19patientsinlatinamerica |